Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical Outcome.

Polioudaki, Hara; Mala, Anastasia; Gkimprixi, Eleni; Papadaki, Maria A; Chantziou, Amanda; Tzardi, Maria; Mavroudis, Dimitris; Agelaki, Sofia; Theodoropoulos, Panayiotis A

Polioudaki, Hara; Mala, Anastasia; Gkimprixi, Eleni; Papadaki, Maria A; Chantziou, Amanda; Tzardi, Maria; Mavroudis, Dimitris; Agelaki, Sofia; Theodoropoulos, Panayiotis A.

Afiliação

Polioudaki H; Laboratory of Biochemistry, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece.
Mala A; Department of Medical Oncology, University General Hospital of Heraklion, 71110 Heraklion, Crete, Greece.
Gkimprixi E; Laboratory of Biochemistry, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece.
Papadaki MA; Laboratory of Translational Oncology, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece.
Chantziou A; Laboratory of Biochemistry, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece.
Tzardi M; Department of Pathology, University General Hospital of Heraklion, 71110 Heraklion, Crete, Greece.
Mavroudis D; Department of Medical Oncology, University General Hospital of Heraklion, 71110 Heraklion, Crete, Greece.
Agelaki S; Laboratory of Translational Oncology, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece.
Theodoropoulos PA; Department of Medical Oncology, University General Hospital of Heraklion, 71110 Heraklion, Crete, Greece.